Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 13Prostatic Neoplasms 9Carcinoma, Hepatocellular 8Liver Neoplasms 6Neoplasm Metastasis 3Melanoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Squamous Intraepithelial Lesions 2Neoplasms 2Lymphatic Metastasis 2Locally Advanced Pancreatic Cancer 2Kidney Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1

Interventions

Etoposide 154Carboplatin 142Cisplatin 104Topotecan 74durvalumab 48atezolizumab 46Irinotecan 44pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 29anlotinib 23PM 01183 22Gemcitabine 21Drug Therapy 20apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Bevacizumab 13amrubicin 11Magnetic Resonance Spectroscopy 11Cyclophosphamide 11rovalpituzumab tesirine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Small Cell Lung Carcinoma × Electroporation × Clear all
NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡